About
Aditya Kohli is a Partner at Frazier Life Sciences focused on company creation, and has co-founded six companies since joining the firm in 2016, including HilleVax, Phathom Pharmaceuticals, and Scout Bio. He was Chief Business Officer of Phathom Pharmaceuticals (2019-2021) and Chief Operating Officer of HilleVax (2020-2024). Earlier he was an Engagement Manager at McKinsey & Company serving biopharmaceutical clients, and he holds a Ph.D. from the UC Berkeley-UCSF joint bioengineering program along with B.S. and M.Eng. degrees in biological engineering from MIT.
Invests in
Biotech
Experience
- Frazier Life SciencesPartnercurrent2025 β present
- Frazier Life SciencesVenture Partner2021 β 2025
- Frazier Life SciencesPrincipal2020 β 2021
- Frazier Life SciencesVice President2018 β 2019
- Frazier Life SciencesSenior Associate2016 β 2017
- HilleVaxBoard Director2021 β 2025
- HilleVaxCBO & Co-Founder2024
- HilleVaxCOO & Co-Founder2020 β 2024
- Scout BioBoard Director & Co-founder2019 β 2024
- Phathom PharmaceuticalsChief Business Officer & Co-founder2019 β 2021
- McKinsey & CompanyEngagement Manager2016New York
- McKinsey & CompanyAssociate2014 β 2016New York City Metropolitan Area
Education
- University of California, San FranciscoDoctor of Philosophy (Ph.D.), Bioengineering
- University of California, BerkeleyDoctor of Philosophy (Ph.D.), Bioengineering
- Massachusetts Institute of TechnologyB.S. / M.Eng., Bioengineering
Same school
Also attended University of California, San Francisco40
+ 34 more
Also attended University of California, Berkeley863
+ 857 more
Also attended Massachusetts Institute of Technology849
+ 843 more
Shared employers
Also worked at Frazier Life Sciences46
+ 40 more
Also worked at Scout Bio6
Also worked at Phathom Pharmaceuticals1
Also worked at McKinsey & Company1,128
+ 1,122 more
Deals Β· 1
Scout Bio IncBoard seat
via Frazier Life Sciences Β· filed Apr 2019 Β· $20M raise
Attribution from SEC filings, press coverage, and firm rosters.








.jpeg)












)







.jpg)






